Cargando…
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series (413)
Objectives: CA-125 has long been utilized as a marker for gynecologic malignancies but can be elevated in many other inflammatory conditions, including lung disease. A retrospective study of tumor markers in non-cancer patients saw a rise in CA-125 values during severe COVID-19 infections. Similarly...
Autores principales: | Mumford, Brigid, Lemon, Lara, Taylor, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462872/ http://dx.doi.org/10.1016/S0090-8258(22)01635-3 |
Ejemplares similares
-
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series
por: Folsom, Susan M., et al.
Publicado: (2022) -
Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?
por: Thayer, Elizabeth, et al.
Publicado: (2023) -
An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
por: Saga, Tsuneo, et al.
Publicado: (1990) -
Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies
por: Schröder, Lars, et al.
Publicado: (2023) -
Schedule of experiment R413
por: Jarlskog, G
Publicado: (1973)